Get your full text copy in PDF
Prevention of Hepatitis B Recurrence after Liver Transplantation
Wojciech G Polak, Andrzej Gladysz, Katarzyna Rotter
Ann Transplant 2005; 10(3): 11-16
ID: 433649
Over the last decade significant improvement in patient and graft survival has been observed after liver transplantation for hepatitis B virus
(HBV)-related liver disease, mostly because of efficient prophylaxis against hepatitis B reinfection. This review discusses different approches in prevention of hepatitis B recurrence in liver recipients including new concepts as vaccination against hepatitis B after liver transplantation. Based on available data combined prophylaxis with hepatitis B immunoglobulin (HBIG) and lamivudine is currently recommended prophylaxis for HBV recurrence after liver transplantation.
This paper has been published under Creative Common Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0) allowing to download articles and share them with others as long as they credit the authors and the publisher, but without permission to change them in any way or use them commercially.
I agree